The board of directors of Sinopharm Group Co., Ltd. announced that on 12 January 2021, the Company received the resignation from Mr. Li Zhiming, the chairman of the Board. Due to personal reasons, Mr. Li Zhiming tendered his resignation as the chairman of the Board, an executive director, the chairman of the nomination committee of the Board, the chairman of the strategy and investment committee of the Board and a member of the legal compliance committee of the Board with immediate effect. Mr. Li has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders and creditors of the Company. The Board has elected Mr. Yu Qingming to act as chairman of the Board on 12 January 2021 in accordance with the articles of association of the Company ("Articles of Association"). Mr. Yu Qingming will perform his duties in accordance with the Company Law, Articles of Association and the relevant bylaws of the Company. The Board will continue to operate in accordance with the applicable laws and regulations to ensure the stability of the Company's operations.